AR070322A1 - PROCEDURE FOR THE QUANTIFICATION OF ANTIGEN NS1 OF DENGUE IN IMMUNOCROMATOGRAPHIC STRIP - Google Patents
PROCEDURE FOR THE QUANTIFICATION OF ANTIGEN NS1 OF DENGUE IN IMMUNOCROMATOGRAPHIC STRIPInfo
- Publication number
- AR070322A1 AR070322A1 ARP090100289A ARP090100289A AR070322A1 AR 070322 A1 AR070322 A1 AR 070322A1 AR P090100289 A ARP090100289 A AR P090100289A AR P090100289 A ARP090100289 A AR P090100289A AR 070322 A1 AR070322 A1 AR 070322A1
- Authority
- AR
- Argentina
- Prior art keywords
- antigen
- dengue
- quantification
- deposited
- procedure
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
- G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Procedimiento no instrumental de un solo paso para la cuantificacion del antígeno de dengue NS1 en fase aguda temprana, presente en muestras de suero, plasma o sangre, a través de su reaccion con un anticuerpo específico monoclonal y/o policlonal contra el antígeno conjugados a oro coloidal, que se encuentra depositado sobre una matriz de la que es liberado al ponerse en contacto con la muestra. Este inmunocomplejo migra a través de un soporte solido y es atrapado al interactuar con otros anticuerpos específicos contra epítopes del antígeno, para los cuatro serotipos del virus, que se encuentran firmemente unidos a una zona reactiva del soporte. El inmunocomplejo se deposita en el área de reaccion, que se evidencia por la aparicion de una marca visualmente detectable que segun el color, indica un resultado positivo a la presencia del antígeno NS1 y por tanto una infeccion por virus de dengue.Non-instrumental single-step procedure for quantification of the dengue NS1 antigen in early acute phase, present in serum, plasma or blood samples, through its reaction with a specific monoclonal and / or polyclonal antibody against the gold-conjugated antigen colloidal, which is deposited on a matrix from which it is released by contacting the sample. This immune complex migrates through a solid support and is trapped by interacting with other specific antibodies against epitopes of the antigen, for the four serotypes of the virus, which are firmly attached to a reactive zone of the support. The immunocomplex is deposited in the reaction area, which is evidenced by the appearance of a visually detectable brand that according to color, indicates a positive result to the presence of the NS1 antigen and therefore a dengue virus infection.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20080015 | 2008-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR070322A1 true AR070322A1 (en) | 2010-03-31 |
Family
ID=40913322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090100289A AR070322A1 (en) | 2008-01-30 | 2009-01-29 | PROCEDURE FOR THE QUANTIFICATION OF ANTIGEN NS1 OF DENGUE IN IMMUNOCROMATOGRAPHIC STRIP |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR070322A1 (en) |
WO (1) | WO2009094955A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102393454A (en) * | 2011-08-24 | 2012-03-28 | 中国检验检疫科学研究院 | Colloidal gold test strip for detecting dengue virus antibody and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2794864A1 (en) * | 1999-06-09 | 2000-12-15 | Pasteur Institut | Early detection of flavivirus infection, especially dengue fever, comprises detecting non-structural glycoprotein (NS1) in a sandwich assay using antibodies specific for the hexameric protein form |
DE102006000305A1 (en) * | 2005-06-22 | 2007-01-04 | Mahidol University | Method for predicting dengue virus infection and development of hemorrhagic fever, comprises detecting both the viral non-structural protein 1 and terminal complement complexes |
-
2009
- 2009-01-29 AR ARP090100289A patent/AR070322A1/en not_active Application Discontinuation
- 2009-01-30 WO PCT/CU2009/000001 patent/WO2009094955A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009094955A2 (en) | 2009-08-06 |
WO2009094955A3 (en) | 2009-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0923199B8 (en) | method for determining the presence of complement-fixing antibodies | |
Litzba et al. | Evaluation of the first commercial chikungunya virus indirect immunofluorescence test | |
AR085624A2 (en) | P-CADERINE ANTIBODIES | |
BRPI1003743A2 (en) | REAGENTS FOR HCV ANTIGEN-ANTIBODY COMBINATION TESTS | |
MX357087B (en) | Multiplex immuno screening assay. | |
MX362075B (en) | Hcv antigen-antibody combination assay and methods and compositions for use therein. | |
AR069797A1 (en) | BIVALENT SPECIFIC ANTIBODIES | |
CO6231057A2 (en) | IMPROVED SENSITIVITY OF DETERMINATION OF THE ANTIBODY PROFILE THROUGH AN INCREASED LAYERING OF REPORTER ANTIBODY | |
AR053948A1 (en) | DETECTION OF AN ANCIENT DIANA INDEPENDENTLY FROM THE PRESENCE OR ABSENCE OF A CORRESPONDING THERAPEUTIC ANTIBODY | |
AR077111A1 (en) | TETRAVALENT BIESPECIFIC PROTEINS FROM UNION TO ANTIGEN | |
CO6280542A2 (en) | BIO-SPECIFIC BIVALENT ANTIBODIES WHERE IN A LIGHT CHAIN AND A HEAVY CHAIN, VARIABLE DOMAINS VL AND VH ARE REPLACED ONE BY THE OTHER | |
CO6280543A2 (en) | BIVESCIENTIAL BIVALENT ANTIBODIES, WHERE THE CONSTANT DOMAINS CL AND CH1 IN A LIGHT CHAIN AND A HEAVY CHAIN ARE REPLACED ONE BY THE OTHER | |
BRPI0719953B8 (en) | high affinity human antibodies to human il-4 receptor | |
RU2013118695A (en) | DEVICES, METHODS AND KITS FOR IMMUNOCHROMATOGRAPHY | |
Hung et al. | A microfluidic immunomagnetic bead-based system for the rapid detection of influenza infections: from purified virus particles to clinical specimens | |
BR112015022844A2 (en) | antibody detection methods for specific donors and systems for | |
AR064186A1 (en) | HIGH SENSITIVITY IMMUNOENSAYS AND KITS FOR THE DETERMINATION OF PEPTIDES AND PROTEINS OF BIOLOGICAL INTEREST | |
CO2018004289A2 (en) | Immunoassay to detect high molecular weight cleaved quininogen | |
AR066863A1 (en) | METHOD FOR DETECTING THE PRESENCE OF THE CALIQUEAMYCIN COMPONENT OF A CALIQUEAMYCIN CARRIER CONJUGATE IN A FLUID SAMPLE AND KIT TO DETERMINE THE CONCENTRATION OF THE CALIQUEAMYCIN PRESENT IN A SAMPLE | |
RU2015104737A (en) | METHOD FOR DETECTING MULTIPECIFIC BINDING AGENT | |
BR112022013298A2 (en) | ANTI-TIGIT ANTIBODIES, MULTI-SPECIFIC ANTIBODIES THAT UNDERSTAND THEM AND METHODS OF USE THEREOF | |
CO6311040A2 (en) | CARE TEST POINT FOR DETECTION OF A SUBJECT EXPOSED TO THE DENGUE VIRUS OR THAT HAS REACHED A CERTAIN LEVEL OF IMMUNITY AGAINST AN ANTIGEN OF THE DENGUE VIRUS | |
CU22968A1 (en) | PROCEDURE FOR THE DETECTION OF ANTI-TRANSGLUTAMINASE ANTIBODIES USED IN THE DIAGNOSIS OF CELIAC DISEASE | |
Li et al. | A highly sensitive chemiluminescent metalloimmunoassay for H1N1 influenza virus detection based on a silver nanoparticle label | |
AR070322A1 (en) | PROCEDURE FOR THE QUANTIFICATION OF ANTIGEN NS1 OF DENGUE IN IMMUNOCROMATOGRAPHIC STRIP |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |